Approaching Clinical Trials Where the Air Hurts Your Face
Colin Enz, CSM & Russell Brierley, Lupin Research Inc, outline the key challenges...
Trending menu:
Colin Enz, CSM & Russell Brierley, Lupin Research Inc, outline the key challenges...
Vice-president of research and development (R&D) Dr Trevor Calkins discusses Pfanstiehl’s active pharmaceutical ingredients (API) contract development and manufacturing organisation (CDMO) philosophy and capabilities at the CPhI/InformEx exhibition
Colin Enz, CSM & Russell Brierley, Lupin Research Inc, outline the key challenges involved in handling cryogenic pharmaceutical products
CTA’s Natacha Girard speaks to Florentina Silva, External Operations Manager, about the challenges of direct-to-patient shipping
Robert Bronstein, Dynavax Technologies, discusses Annex 16 and what every clinical supply chain manager needs to know to avoid potential QP release pitfalls
CTA highlights the best articles from the month of August 2018
CTA Editor Henry Kerali explores the topic of temperature excursions asking what constitutes a robust cold chain strategy
Henk Dieteren, Senior Clinical Supply Manager, Grünenthal, speaks to CTA Editor Henry Kerali about monitoring temperature-sensitive shipments
Guglielmo Migliori runs the rule on the advantages and disadvantages of Just-in-Time labelling
CTA’s Lu Tikrity explores the implications of the Falsified Medicines Directive as the deadline looms ever larger
Paul Jeng, PhD, Infectious Diseases Analyst, GlobalData, explains how the development of vaccines must change to combat viral outbreaks
Go Top